RolfoLab
@rolfolab.bsky.social
Liquid Biopsy & Biomarkers Lab 🩸 🧬
🏫 The James Comprehensive Cancer Center - The Ohio State University
🏫 The James Comprehensive Cancer Center - The Ohio State University
Reposted by RolfoLab
Early Registration Is Open for #ISLB25!
Register by October 10, 2025, to take advantage of discounted rates. Full In-Person Registration Includes access to all Scientific Sessions (except ticketed sessions), entry to the Exhibition Hall, and more!
Register now at 2025.islb.info/lrdo
Register by October 10, 2025, to take advantage of discounted rates. Full In-Person Registration Includes access to all Scientific Sessions (except ticketed sessions), entry to the Exhibition Hall, and more!
Register now at 2025.islb.info/lrdo
July 21, 2025 at 8:20 AM
Early Registration Is Open for #ISLB25!
Register by October 10, 2025, to take advantage of discounted rates. Full In-Person Registration Includes access to all Scientific Sessions (except ticketed sessions), entry to the Exhibition Hall, and more!
Register now at 2025.islb.info/lrdo
Register by October 10, 2025, to take advantage of discounted rates. Full In-Person Registration Includes access to all Scientific Sessions (except ticketed sessions), entry to the Exhibition Hall, and more!
Register now at 2025.islb.info/lrdo
Reposted by RolfoLab
🩸🚀 New Insights in Liquid Biopsy! 🧬
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
International Society of Liquid Biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
Circulating tumor DNA (ctDNA) testing has transformed precision oncology by enabling
the non-invasive detection of actionable mutations. To facilitate broader clinical
adoption and improve testing acc...
www.journalofliquidbiopsy.com
May 31, 2025 at 6:16 AM
🩸🚀 New Insights in Liquid Biopsy! 🧬
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
Reposted by RolfoLab
🚨Excited to represent the @islb.info at #ASCO25!
Swing by our booth, we’re ready to talk about #LiquidBiopsy and opportunities!
Got questions about the society? We’ve got answers. Come to connect!🩸
@ascocancer.bsky.social @christianrolfo.bsky.social @rolfolab.bsky.social
Swing by our booth, we’re ready to talk about #LiquidBiopsy and opportunities!
Got questions about the society? We’ve got answers. Come to connect!🩸
@ascocancer.bsky.social @christianrolfo.bsky.social @rolfolab.bsky.social
May 27, 2025 at 4:07 PM
🚨Excited to represent the @islb.info at #ASCO25!
Swing by our booth, we’re ready to talk about #LiquidBiopsy and opportunities!
Got questions about the society? We’ve got answers. Come to connect!🩸
@ascocancer.bsky.social @christianrolfo.bsky.social @rolfolab.bsky.social
Swing by our booth, we’re ready to talk about #LiquidBiopsy and opportunities!
Got questions about the society? We’ve got answers. Come to connect!🩸
@ascocancer.bsky.social @christianrolfo.bsky.social @rolfolab.bsky.social
Reposted by RolfoLab
Very honored of this important recognition in my born country. Blessed to share this special moment with my family, friends and great colleagues from Argentina 🇦🇷 looking forward to continue working with @UBAonline from OSU @OhioStateMedOnc ! Thanks to all my team @rolfolab.bsky.social
May 12, 2025 at 6:30 PM
Very honored of this important recognition in my born country. Blessed to share this special moment with my family, friends and great colleagues from Argentina 🇦🇷 looking forward to continue working with @UBAonline from OSU @OhioStateMedOnc ! Thanks to all my team @rolfolab.bsky.social
New research from the #VISION trial of #tepotinib in #NSCLC with #METex14 skipping highlights key differences when patients are identified by LBxvs TBx.
➡️ #Tepotinib showed robust efficacy regardless of biopsy type
@christianrolfo.bsky.social @oncoalert.bsky.social
➡️ #Tepotinib showed robust efficacy regardless of biopsy type
@christianrolfo.bsky.social @oncoalert.bsky.social
May 5, 2025 at 1:52 PM
New research from the #VISION trial of #tepotinib in #NSCLC with #METex14 skipping highlights key differences when patients are identified by LBxvs TBx.
➡️ #Tepotinib showed robust efficacy regardless of biopsy type
@christianrolfo.bsky.social @oncoalert.bsky.social
➡️ #Tepotinib showed robust efficacy regardless of biopsy type
@christianrolfo.bsky.social @oncoalert.bsky.social
Visit at #AACR25 the poster by Dr. Eswar Shankar on “Synergistic Inhibition of TNBC via EZH2 inhibition and D1 Receptor Agonism”
@OSUCCC_James
@osuwexmed.bsky.social
@christianrolfo.bsky.social
@theaacr.bsky.social
pbs.twimg.com/media/Gpay9i...
@OSUCCC_James
@osuwexmed.bsky.social
@christianrolfo.bsky.social
@theaacr.bsky.social
pbs.twimg.com/media/Gpay9i...
April 26, 2025 at 11:42 AM
Visit at #AACR25 the poster by Dr. Eswar Shankar on “Synergistic Inhibition of TNBC via EZH2 inhibition and D1 Receptor Agonism”
@OSUCCC_James
@osuwexmed.bsky.social
@christianrolfo.bsky.social
@theaacr.bsky.social
pbs.twimg.com/media/Gpay9i...
@OSUCCC_James
@osuwexmed.bsky.social
@christianrolfo.bsky.social
@theaacr.bsky.social
pbs.twimg.com/media/Gpay9i...
Reposted by RolfoLab
Super excited to share the review I wrote with Carolina Reduzzi published in the Journal of Liquid Biopsy on the transformative impact of LB in oncology! 🩸🔬
LB is reshaping cancer care 💥
Check it out 👉 pubmed.ncbi.nlm.nih.gov/40255897/
@islb.info @christianrolfo.bsky.social @rolfolab.bsky.social
LB is reshaping cancer care 💥
Check it out 👉 pubmed.ncbi.nlm.nih.gov/40255897/
@islb.info @christianrolfo.bsky.social @rolfolab.bsky.social
April 21, 2025 at 7:51 PM
Super excited to share the review I wrote with Carolina Reduzzi published in the Journal of Liquid Biopsy on the transformative impact of LB in oncology! 🩸🔬
LB is reshaping cancer care 💥
Check it out 👉 pubmed.ncbi.nlm.nih.gov/40255897/
@islb.info @christianrolfo.bsky.social @rolfolab.bsky.social
LB is reshaping cancer care 💥
Check it out 👉 pubmed.ncbi.nlm.nih.gov/40255897/
@islb.info @christianrolfo.bsky.social @rolfolab.bsky.social
Reposted by RolfoLab
Congrats Roberto! And welcome to @rolfolab.bsky.social !!!
Honored to be here at hashtag #TexasLung25 in #Austin as one of the 10 winners of the poster competition 🏅
Grateful for the chance to meet with exceptional people 👐
@stephenvliu.bsky.social @tinacascone @christianrolfo.bsky.social
Grateful for the chance to meet with exceptional people 👐
@stephenvliu.bsky.social @tinacascone @christianrolfo.bsky.social
April 11, 2025 at 11:05 AM
Congrats Roberto! And welcome to @rolfolab.bsky.social !!!
Reposted by RolfoLab
Day 3 at #TexasLung25 diving into diagnostics, #MRD, and #LiquidBiopsy with an outstanding faculty! 🩸🔬
Learning from the best: @christianrolfo.bsky.social @davidgandera @WadeIams @osucccjames.bsky.social @rolfolab.bsky.social
Exciting discussions shaping the future of #lungcancer testing! 📚
Learning from the best: @christianrolfo.bsky.social @davidgandera @WadeIams @osucccjames.bsky.social @rolfolab.bsky.social
Exciting discussions shaping the future of #lungcancer testing! 📚
April 12, 2025 at 4:32 PM
Day 3 at #TexasLung25 diving into diagnostics, #MRD, and #LiquidBiopsy with an outstanding faculty! 🩸🔬
Learning from the best: @christianrolfo.bsky.social @davidgandera @WadeIams @osucccjames.bsky.social @rolfolab.bsky.social
Exciting discussions shaping the future of #lungcancer testing! 📚
Learning from the best: @christianrolfo.bsky.social @davidgandera @WadeIams @osucccjames.bsky.social @rolfolab.bsky.social
Exciting discussions shaping the future of #lungcancer testing! 📚
Reposted by RolfoLab
Honored to be here at hashtag #TexasLung25 in #Austin as one of the 10 winners of the poster competition 🏅
Grateful for the chance to meet with exceptional people 👐
@stephenvliu.bsky.social @tinacascone @christianrolfo.bsky.social
Grateful for the chance to meet with exceptional people 👐
@stephenvliu.bsky.social @tinacascone @christianrolfo.bsky.social
April 11, 2025 at 1:49 AM
Honored to be here at hashtag #TexasLung25 in #Austin as one of the 10 winners of the poster competition 🏅
Grateful for the chance to meet with exceptional people 👐
@stephenvliu.bsky.social @tinacascone @christianrolfo.bsky.social
Grateful for the chance to meet with exceptional people 👐
@stephenvliu.bsky.social @tinacascone @christianrolfo.bsky.social
Reposted by RolfoLab
Navigating the future of #LiquidBiopsy with @christianrolfo.bsky.social at #poles25
From screening to resistance tracking—MRD is reshaping how we detect, treat, and monitor cancer.
Tissue vs liquid? It’s not a battle—it’s a partnership.
@rolfolab.bsky.social @islb.info @oncoalert.bsky.social
From screening to resistance tracking—MRD is reshaping how we detect, treat, and monitor cancer.
Tissue vs liquid? It’s not a battle—it’s a partnership.
@rolfolab.bsky.social @islb.info @oncoalert.bsky.social
April 5, 2025 at 4:49 PM
Navigating the future of #LiquidBiopsy with @christianrolfo.bsky.social at #poles25
From screening to resistance tracking—MRD is reshaping how we detect, treat, and monitor cancer.
Tissue vs liquid? It’s not a battle—it’s a partnership.
@rolfolab.bsky.social @islb.info @oncoalert.bsky.social
From screening to resistance tracking—MRD is reshaping how we detect, treat, and monitor cancer.
Tissue vs liquid? It’s not a battle—it’s a partnership.
@rolfolab.bsky.social @islb.info @oncoalert.bsky.social
Reposted by RolfoLab
As always, an insightful presentation by @UmbertoMalapelle
➡️ "From single gene testing to CGP." 🔬✨
at #ELCC25 @myesmo.bsky.social
We must continue this path to improve treatment selection!
@islb.info #precisiononcology #lungcancer
⬇️ Key message
➡️ "From single gene testing to CGP." 🔬✨
at #ELCC25 @myesmo.bsky.social
We must continue this path to improve treatment selection!
@islb.info #precisiononcology #lungcancer
⬇️ Key message
March 27, 2025 at 10:15 AM
As always, an insightful presentation by @UmbertoMalapelle
➡️ "From single gene testing to CGP." 🔬✨
at #ELCC25 @myesmo.bsky.social
We must continue this path to improve treatment selection!
@islb.info #precisiononcology #lungcancer
⬇️ Key message
➡️ "From single gene testing to CGP." 🔬✨
at #ELCC25 @myesmo.bsky.social
We must continue this path to improve treatment selection!
@islb.info #precisiononcology #lungcancer
⬇️ Key message
Reposted by RolfoLab
Today, I had the pleasure of presenting to the @MtSinaiASCOOSIG on the role of #liquidbiopsy in clinical practice and #precisiononcology! ❤️ An incredibly dynamic and engaging group! Great discussions and insights!
@osucccjames.bsky.social @rolfolab.bsky.social @christianrolfo.bsky.social
@unige
@osucccjames.bsky.social @rolfolab.bsky.social @christianrolfo.bsky.social
@unige
March 25, 2025 at 9:34 PM
Today, I had the pleasure of presenting to the @MtSinaiASCOOSIG on the role of #liquidbiopsy in clinical practice and #precisiononcology! ❤️ An incredibly dynamic and engaging group! Great discussions and insights!
@osucccjames.bsky.social @rolfolab.bsky.social @christianrolfo.bsky.social
@unige
@osucccjames.bsky.social @rolfolab.bsky.social @christianrolfo.bsky.social
@unige
Reposted by RolfoLab
📢 Exciting update in the field of liquid biopsy! A new editorial highlights the essential role of the International Society of Liquid Biopsy (ISLB) in establishing quality framework for LB clinical implementation. 🧬🩸
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
March 18, 2025 at 2:46 PM
📢 Exciting update in the field of liquid biopsy! A new editorial highlights the essential role of the International Society of Liquid Biopsy (ISLB) in establishing quality framework for LB clinical implementation. 🧬🩸
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
Reposted by RolfoLab
🚨 Out in @natrevclinoncol.bsky.social
📌ctDNA helps uncover resistance mechanisms
📌Standardized protocols are crucial for improving applications
📌ctDNA + tissue provides a more comprehensive view
nature.com/articles/s41...
@christianrolfo.bsky.social @osucccjames.bsky.social
📌ctDNA helps uncover resistance mechanisms
📌Standardized protocols are crucial for improving applications
📌ctDNA + tissue provides a more comprehensive view
nature.com/articles/s41...
@christianrolfo.bsky.social @osucccjames.bsky.social
March 17, 2025 at 12:00 PM
🚨 Out in @natrevclinoncol.bsky.social
📌ctDNA helps uncover resistance mechanisms
📌Standardized protocols are crucial for improving applications
📌ctDNA + tissue provides a more comprehensive view
nature.com/articles/s41...
@christianrolfo.bsky.social @osucccjames.bsky.social
📌ctDNA helps uncover resistance mechanisms
📌Standardized protocols are crucial for improving applications
📌ctDNA + tissue provides a more comprehensive view
nature.com/articles/s41...
@christianrolfo.bsky.social @osucccjames.bsky.social
Don’t miss this chance to contribute!
Now you can find the link to complete our @islb.info survey in the @oncoalert.bsky.social newsletter! 📨
It only takes 5 min to help us understand how LB 🩸 is reshaping clinical practice worldwide!
bit.ly/43JzN03
@christianrolfo.bsky.social @rolfolab.bsky.social @weoncologists.bsky.social
It only takes 5 min to help us understand how LB 🩸 is reshaping clinical practice worldwide!
bit.ly/43JzN03
@christianrolfo.bsky.social @rolfolab.bsky.social @weoncologists.bsky.social
March 14, 2025 at 4:27 PM
Don’t miss this chance to contribute!
Great opportunity to gain valuable insights into METex14 skipping NSCLC! 🎦
Diving into the latest on #METex14 skipping #NSCLC, from testing to treatment, with an outstanding panel of experts! 🌟🔬
--> bit.ly/3DFSzLi
Panelists:
@christianrolfo.bsky.social
#UmbertoMalapelle
#YasushiYatabe
#MervatMahrous
Organizer:
#touchOncology
@rolfolab.bsky.social @oncoalert.bsky.social
--> bit.ly/3DFSzLi
Panelists:
@christianrolfo.bsky.social
#UmbertoMalapelle
#YasushiYatabe
#MervatMahrous
Organizer:
#touchOncology
@rolfolab.bsky.social @oncoalert.bsky.social
March 13, 2025 at 3:26 PM
Great opportunity to gain valuable insights into METex14 skipping NSCLC! 🎦
Congratulations Roberto! Well deserved! @osucccjames.bsky.social
Honored to be among the winners of the #TexasLung25 Poster Competition! 🎉 Grateful for the opportunity to share my research and contribute to the future of #lungcancer!
@christianrolfo.bsky.social @rolfolab.bsky.social @stephenvliu.bsky.social @osucccjames.bsky.social
➡️ hubs.la/Q03bqnlB0
@christianrolfo.bsky.social @rolfolab.bsky.social @stephenvliu.bsky.social @osucccjames.bsky.social
➡️ hubs.la/Q03bqnlB0
March 12, 2025 at 7:45 AM
Congratulations Roberto! Well deserved! @osucccjames.bsky.social
Reposted by RolfoLab
The HER2 protein is becoming a crucial target not only in breast cancer but also in other tumor subtypes. 🔬✨ Super experts discuss the role of IHC in #lungcancer and #ovariancancer!
@christianrolfo.bsky.social @rolfolab.bsky.social
@osucccjames.bsky.social
#HER2 #IHC #Targettherapy
@christianrolfo.bsky.social @rolfolab.bsky.social
@osucccjames.bsky.social
#HER2 #IHC #Targettherapy
JOIN US for a discussion on HER2🧬testing & evolving role of IHC🔬 in hashtag#LungCancer & hashtag#OvarianCancer
REGISTER HERE👇👇
buff.ly/7F6ztd4
JOIN US TUESDAY MARCH 11, 2025
REGISTER HERE👇👇
buff.ly/7F6ztd4
JOIN US TUESDAY MARCH 11, 2025
March 11, 2025 at 1:01 PM
The HER2 protein is becoming a crucial target not only in breast cancer but also in other tumor subtypes. 🔬✨ Super experts discuss the role of IHC in #lungcancer and #ovariancancer!
@christianrolfo.bsky.social @rolfolab.bsky.social
@osucccjames.bsky.social
#HER2 #IHC #Targettherapy
@christianrolfo.bsky.social @rolfolab.bsky.social
@osucccjames.bsky.social
#HER2 #IHC #Targettherapy
Reposted by RolfoLab
✨ Insightful presentation by @manelesteller.bsky.social from
@carrerasijc.bsky.social at @osuwexmed.bsky.social
Starting from #epigenetics to #spatialtranscriptomics, unlocking a deeper understanding of tumor biology and cancer treatment! 🔬🧬💊
@christianrolfo.bsky.social @rolfolab.bsky.social
@carrerasijc.bsky.social at @osuwexmed.bsky.social
Starting from #epigenetics to #spatialtranscriptomics, unlocking a deeper understanding of tumor biology and cancer treatment! 🔬🧬💊
@christianrolfo.bsky.social @rolfolab.bsky.social
March 5, 2025 at 6:32 PM
✨ Insightful presentation by @manelesteller.bsky.social from
@carrerasijc.bsky.social at @osuwexmed.bsky.social
Starting from #epigenetics to #spatialtranscriptomics, unlocking a deeper understanding of tumor biology and cancer treatment! 🔬🧬💊
@christianrolfo.bsky.social @rolfolab.bsky.social
@carrerasijc.bsky.social at @osuwexmed.bsky.social
Starting from #epigenetics to #spatialtranscriptomics, unlocking a deeper understanding of tumor biology and cancer treatment! 🔬🧬💊
@christianrolfo.bsky.social @rolfolab.bsky.social
Reposted by RolfoLab
⏱️ To-do list for today: Tune in to the live webinar by
@iaslc.bsky.social covering key highlights from the 2024 Hot Topic in Basic & Translational Science Conference! 🔬🧬 Don't miss out on the latest breakthroughs!
@christianrolfo.bsky.social @rolfolab.bsky.social
www.iaslc.org/meetings-web...
@iaslc.bsky.social covering key highlights from the 2024 Hot Topic in Basic & Translational Science Conference! 🔬🧬 Don't miss out on the latest breakthroughs!
@christianrolfo.bsky.social @rolfolab.bsky.social
www.iaslc.org/meetings-web...
2024 Hot Topic in Basic & Translational Science Conference Highlights | IASLC
IASLC presents a one-hour, live session focused on key highlights from the 2024 Hot Topic in Basic & Translational Science Conference. This webinar will ser ...
www.iaslc.org
February 12, 2025 at 12:10 PM
⏱️ To-do list for today: Tune in to the live webinar by
@iaslc.bsky.social covering key highlights from the 2024 Hot Topic in Basic & Translational Science Conference! 🔬🧬 Don't miss out on the latest breakthroughs!
@christianrolfo.bsky.social @rolfolab.bsky.social
www.iaslc.org/meetings-web...
@iaslc.bsky.social covering key highlights from the 2024 Hot Topic in Basic & Translational Science Conference! 🔬🧬 Don't miss out on the latest breakthroughs!
@christianrolfo.bsky.social @rolfolab.bsky.social
www.iaslc.org/meetings-web...
Reposted by RolfoLab
Amazing group of medical oncologists that I am privileged to work with every day and call friends @stoverlab.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @quirogad.bsky.social @osucccjames.bsky.social
February 1, 2025 at 9:23 PM
Amazing group of medical oncologists that I am privileged to work with every day and call friends @stoverlab.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @quirogad.bsky.social @osucccjames.bsky.social
Reposted by RolfoLab
Don't miss the chance to dive into this interesting discussion on lung cancer with an incredible faculty! 🔎🫁💊
#lungcancer
#myESMO
#DeepDiveLungCancer
@christianrolfo.bsky.social @rolfolab.bsky.social
ow.ly/vbSt50UPrrS
#lungcancer
#myESMO
#DeepDiveLungCancer
@christianrolfo.bsky.social @rolfolab.bsky.social
ow.ly/vbSt50UPrrS
February 3, 2025 at 12:56 PM
Don't miss the chance to dive into this interesting discussion on lung cancer with an incredible faculty! 🔎🫁💊
#lungcancer
#myESMO
#DeepDiveLungCancer
@christianrolfo.bsky.social @rolfolab.bsky.social
ow.ly/vbSt50UPrrS
#lungcancer
#myESMO
#DeepDiveLungCancer
@christianrolfo.bsky.social @rolfolab.bsky.social
ow.ly/vbSt50UPrrS
🎯
The ISLB created this survey to understand how to improve the use of #liquidbiopsy in clinical oncology!
Don't miss the opportunity to shape the future of LB in cancer patients!! 🔥
@christianrolfo.bsky.social @robertoboreamd.bsky.social
The ISLB created this survey to understand how to improve the use of #liquidbiopsy in clinical oncology!
Don't miss the opportunity to shape the future of LB in cancer patients!! 🔥
@christianrolfo.bsky.social @robertoboreamd.bsky.social
Survey Participation Request on Behalf of @isliquidbiopsy & @OncoAlert
Oncologist Attitudes and Practices on Liquid Biopsy
👉 https://buff.ly/3Cvf8BJ
This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.
Oncologist Attitudes and Practices on Liquid Biopsy
👉 https://buff.ly/3Cvf8BJ
This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.
January 30, 2025 at 3:43 PM
🎯
The ISLB created this survey to understand how to improve the use of #liquidbiopsy in clinical oncology!
Don't miss the opportunity to shape the future of LB in cancer patients!! 🔥
@christianrolfo.bsky.social @robertoboreamd.bsky.social
The ISLB created this survey to understand how to improve the use of #liquidbiopsy in clinical oncology!
Don't miss the opportunity to shape the future of LB in cancer patients!! 🔥
@christianrolfo.bsky.social @robertoboreamd.bsky.social
Reposted by RolfoLab
🚨 Share your expertise in the liquid biopsy field! 🌟 Participate in the #ISLB survey to help shape strategies for improving #liquidbiopsies in clinical oncology.
Let’s advance precision care for medical oncologists together! 🩺🔬
@christianrolfo.bsky.social @rolfolab.bsky.social
Let’s advance precision care for medical oncologists together! 🩺🔬
@christianrolfo.bsky.social @rolfolab.bsky.social
Survey Participation Request on Behalf of @isliquidbiopsy & @OncoAlert
Oncologist Attitudes and Practices on Liquid Biopsy
👉 https://buff.ly/3Cvf8BJ
This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.
Oncologist Attitudes and Practices on Liquid Biopsy
👉 https://buff.ly/3Cvf8BJ
This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.
January 30, 2025 at 3:40 PM
🚨 Share your expertise in the liquid biopsy field! 🌟 Participate in the #ISLB survey to help shape strategies for improving #liquidbiopsies in clinical oncology.
Let’s advance precision care for medical oncologists together! 🩺🔬
@christianrolfo.bsky.social @rolfolab.bsky.social
Let’s advance precision care for medical oncologists together! 🩺🔬
@christianrolfo.bsky.social @rolfolab.bsky.social